Home › Atherosclerosis › NCT04496947

Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study

Who can join

Ages 30 to 65 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* • Aged between 30-65 years

  * Identifies as having increased levels of stress and/or has a Perceived Stress Scale (PSS) score \>5 at baseline, and is interested in participating

Exclusion Criteria:

* Perceived Stress Scale (PSS) score \<6

About the study

The plot study aims to evaluate the effect of 8 weeks of stress reducing intervention on atherosclerotic plaque inflammation in adults, as quantified by positron emission tomography (PET) with fluorine-2-deoxy-D-glucose (FDG) in individuals with increased psychosocial stress.

What is being tested

• Stress Reduction (behavioral)

Sponsor: Massachusetts General Hospital · Participants: 30 · Started: Sep 1, 2018

Contact the study team

• Ahmed Tawakol, MD · Phone: 6177243699

Official record on ClinicalTrials.gov — NCT04496947

Locations in the U.S.

Conditions

• Atherosclerosis

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.